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Stroke is one of the major morbidities in children with sickle cell anaemia, and the 
degree of anaemia itself is a risk factor (Azab et al, 2014; Dowling et al, 2012). 
Those with homozygous sickle cell disease (HbSS; SCD) are particularly at risk of 
clinically “overt” stroke (Earley et al, 1998) with an even higher risk of “covert” or 
clinically silent strokes (DeBaun & Kirkham, 2016).  This is where the field gets 
complicated and the “haematological perspective” differs from the neurological. The 
focal neurological deficits that result from large artery strokes are relatively well 
recognized but for the smaller ischaemic events, separation of “silent” from “overt” 
depends more on the anatomical location of the smaller lesions rather than the 
mechanism of the stroke.  This has muddled the distinction of the causes, the 
consequences, and the treatment of the two poorly named types.  The ischaemic 
lesions in the deep watershed areas (typically more associated with hypoperfusion 
than to large arterial occlusion) can occur without focal neurological deficits unless 
they happen to injure, for example, the descending motor pathways where they 
result in an easily recognizable clinical deficit in motor function and thus are 
identified as “overt” stroke.   An ischaemic lesion of the same size and occurring due 
the same physiologic mechanism but located centimetres or even millimetres away 
could easily go undetected and be identified only later on MRI as a “silent cerebral 
infarction” (Figure 1).   
 
So what is the mechanism of either or any of these infarctions?   Historically this was 
thought to be a result of vaso-occlusive disease similar to that which occurs during a 
sickle cell crisis.  However, pathological studies demonstrated that the majority of 
children who have SCD and overt stroke have a steno-occlusive arteriopathy usually 
involving the distal internal carotid, proximal middle cerebral, and anterior cerebral 
arteries of the Circle of Willis (Stockman et al, 1972).  Sometimes this occurs in 
association with the formation of moyamoya vessels and collaterals and is 
associated with increased risk of recurrent stroke.  These observations gave rise to 
the “occlusive vascular model” of stroke in SCD where endothelial hyperplasia in 
medium to large vessels increased the risk of thrombo-embolism while sludging of 
sickle cells within the cerebral microcirculation led to small vessel infarction (Pavlakis 
et al, 1989). 
 
There is also evidence to support a “haemodynamic ischaemic model” of stroke in 
children with SCD.  The normal response to ischaemia is vasodilation which is 
usually accompanied by an increased distal arterial blood flow and consequent 
increased cerebral perfusion.   In this issue, Kosinski and co-workers have used MRI 
arterial spin labelling techniques to demonstrate increased cerebral blood flow in 
neurologically normal children with SCD compared to controls.  They also 
demonstrated that children with SCD have a decreased ability to dilate their cerebral 
vessels in response to hypercapnia and both are highly correlated with the degree of 
anaemia.  That is, they have a lower cerebrovascular reserve.  So, untransfused 
children with SCD approach the upper limit of cerebral vasodilation with chronically 
increased cerebral perfusion rates.  So, despite increased tissue oxygen supply, an 
uncoupling of cerebral flow and cerebral perfusion may occur under any condition 
where there is an additional requirement for oxygen supply (e.g. increased metabolic 
demand during seizures, hypotensive episodes, or local embolic events) putting the 
child at risk of haemodynamic ischaemic sequelae including stroke that is either 
silent or overt, depending on its location.   
 
Thus, clinical events that are common in SCD such as acute hypoxia (from acute 
chest syndrome) or acute exacerbation of anaemia (from aplastic crisis or acute 
splenic sequestration) may cause injury if cerebral blood flow is already close to the 
ischaemic threshold, either because flow is low distal to stenotic vessels or because 
the CBF is maximal, so that the reserve is exhausted.  This may occur under any 
condition where there is an additional requirement for oxygen supply.  Acute silent 
infarction has been demonstrated in children with and without SCD in the setting of 
an acute anemic event (Dowling, et al., 2012).  In these circumstances, 
hypoperfusion and reduced cerebrovascular reserve in the borderzones between the 
large vessels may lead directly to ischaemia or may precipitate thrombosis in small 
vessels secondary to slow passage of microemboli and local ‘sludging’. The brain 
may also be particularly vulnerable to hypoxic-ischaemic damage during sleep as 
CBF increases during rapid eye movement sleep and during the hypercapnia which 
is common in SCD (Kaleyias et al, 2008), so that the cerebrovascular reserve is 
likely to be compromised in the context of the hypoxia associated with obstructive 
sleep apnoea (Rosen et al, 2014).  
 
Risk factors for overt and covert stroke include intracranial and cervical arteriopathy 
(Telfer et al, 2011; Bernaudin et al, 2015) as well as the severity of anaemia (Ohene-
Frempong et al, 1998; DeBaun et al, 2012).   But these two risk factors do not 
correlate directly with the “occlusive vascular” and the “haemodynamic ischemic” 
models of stroke discussed above.  The STOP clinical trial of transfusion in SCD 
demonstrated the association between increased cerebral blood flow velocities as 
detected by TCD and stroke risk. Children with TCD velocities >170 cm/sec had a 
stroke risk of 7% over 36 months and children with TCD velocities >200 cm/sec had 
a stroke risk of 40% over 36 months. Children without stroke were randomly 
assigned to treatment with blood transfusion or no (standard) treatment.  A 90% 
reduction in stroke risk was observed in the transfused group and the trial was 
terminated early given overwhelming evidence of the protection offered by 
transfusion (Adams, et al., 1998).  TCD velocity rather than MRA abnormality was 
the strongest predictor of stroke between the transfused and non-transfused groups.  
Lee et al (2006) also reported in the extended follow-up of the STOP trial patients all 
six patients who developed stroke had elevated TCD velocities, but only two had 
abnormal MRAs.  This would suggest that steno-occlusive disease is not necessarily 
the sole or major cause of stroke in SCD, and that cerebral haemodynamics have a 
significant role. The children in Kosinski’s study did not have steno-occlusive disease 
(although disease of the neck vessels may not have been completely excluded) but 
presumably, the exhausted cerebrovascular reserve in vessels distal to areas of 
stenosis only further heightens stroke risk in affected children.  
 
Kosinki’s study provides evidence that CVR is related to the severity of anaemia in 
SCD. The data from Hurlet-Jensen et al., (1994) suggests that there could be an 
additional effect of HbS itself on CBF in addition to the effect of the anaemia itself. It 
would be of interest to compare children with other anaemias and to include data on 
haemoglobin oxygen saturation and HbS% (Borzage et al, 2016). Relative 
hypotension, “ischaemic hypoxia”, (Pegelow et al, 1997) and low oxygen saturation, 
“hypoxic hypoxia”, might add to the effect of the “anaemic hypoxia” in reducing CVR. 
This relationship between anaemia and CBF/CVR demonstrated by Kosinski et al 
needs to be explored in children with sickle vasculopathy and focal hypoperfusion 
and the mechanisms of ischaemic injury in SCD warrant reexamination with these 
more sophisticated techniques.   
 
The problem of stroke in SCD is one of multiple, overlapping challenges to the 
cerebrovascular physiology including not just the anaemia and resultant high flow 
and decreased cerebrovascular reserve, but also thromobotic and embolic disease 
as well additional concerns of stenosis, hyperviscosity, hypoxia, and potentially 
cerebral venous thrombosis with venous infarction.   It is not clear how much of the 
problem of cerebral ischaemia in SCD is due to the sickle haemoglobin and how 
much is due to the anaemia, but more of these dynamic assessments of cerebral 
blood flow and vascular reserve that Kosinski et al provide are needed, including 
measures of cerebral metabolism (Jordan et al, 2016) ideally at the bedside (Nur et 
al, 2009).   Are children with SCD and vasculopathy living outside the range of a 
protective cerebrovascular reserve? Is this important in terms of brain development 
and acute (Figure 2) or long-term cognitive difficulties? Can assessments of cerebral 
blood flow and cerebrovascular reserve serve to stratify risk or individualize 
treatment regimens?  Can such approaches and a more neurological perspective of 
stroke be applied to clinical trials?  These questions need urgent exploration.    
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Figure 1   
Small Deep Watershed Infarctions in Children with SCD 
  
FLAIR MRI images of two children with SCD showing multiple infarctions (areas of 
increased signal as indicated by the arrows) in the bilateral white matter in the “deep 
watershed” regions rather than a typical arterial distribution.  The lesions in A did not cause 
focal neurologic symptoms and thus this child had silent cerebral infarctions while the lesions 
in B resulted in focal neurologic deficits and thus this child had an overt stroke. 
 
 
Figure 2
 
The Effect of Severe Anaemia on Cognitive Function 
A 6 year old boy (without SCD) presented with fever and joint pain with an acute haemolytic 
anaemia of unknown etiology with initial haemoglobin 37 g/L.  He was judged to be 
“neurologically normal”.  He was asked to write “The cat is black” as part of a more detailed 
evaluation.  He was transfused and on day 3 with haemoglobin 93g/L, he repeated the writing 
task with improved performance.   
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